BEIJING, July 26, 2017 -- Jumei International Holding Limited (NYSE:JMEI) (“Jumei” or the “Company”), China’s leading online retailer of beauty products, today announced that Mr. Yusen Dai, the co-founder of the Company, has tendered his resignation from his position as a director and the vice president of products of the Company for personal reasons. The resignation of Mr. Dai has taken effect immediately.
Mr. Leo Ou Chen, founder, chairman and CEO of Jumei, stated, “We greatly appreciate the contributions Yusen made since the inception of our Company. We respect his decision and wish him the very best in his future pursuits.”
About Jumei
Jumei (NYSE:JMEI) is China’s leading online retailer of beauty products. Jumei’s internet platform is a trusted destination for consumers to discover and purchase branded beauty products, baby, children and maternity products, light luxury products, health supplements and other products through the Company’s jumei.com and jumeiglobal.com websites and mobile application. Leveraging its deep understanding of customer needs and preferences, as well as its strong merchandizing capabilities, Jumei has adopted multiple effective sales formats to encourage product purchases on its platform, including curated sales, online shopping mall and flash sales. More information about Jumei can be found at http://ir.jumei.com.
For investor and media inquiries, please contact: Jumei International Holding Limited Ms. Cindy Cao Senior Reporting Manager Phone: +86-10-5676-6824 Email: [email protected] Christensen In China Mr. Christian Arnell Phone: +86-10-5900-1548 Email: [email protected] In US Ms. Linda Bergkamp Phone: +1-480-614-3004 Email: [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



